(CORT) Corcept Therapeutics - Performance 145.1% in 12m
CORT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
82.47%
#2 in Peer-Group
Rel. Strength
96.25%
#286 in Stock-Universe
Total Return 12m
145.05%
#12 in Peer-Group
Total Return 5y
360.01%
#7 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 61.3 |
| P/E Forward | 55.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 114.22 USD |
| 52 Week Low | 28.15 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 18.09 |
| Buy/Sell Signal +-5 | -0.39 |
| Support / Resistance | Levels |
|---|---|
| Support | 59.9, 51.1, 45.6 |
| Resistance | 100.0, 70.3 |
12m Total Return: CORT (145.1%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: CORT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CORT
| Total Return (including Dividends) | CORT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -4.50% | 4.35% | 1.11% |
| 3 Months | 21.04% | -6.89% | 5.58% |
| 12 Months | 145.05% | -5.08% | 10.51% |
| 5 Years | 360.01% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | CORT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -59.9% | 65.8% | 69.9% |
| 3 Months | 40% | -72% | 69.3% |
| 12 Months | 93.5% | -62.2% | 43.2% |
| 5 Years | 74.8% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #149 | -8.48% | -5.54% |
| 3 Month | #38 | 30.00% | 14.65% |
| 12 Month | #11 | 158.17% | 121.75% |
| 5 Years | #8 | 205.59% | 119.98% |
FAQs
Does Corcept Therapeutics (CORT) outperform the market?
Yes,
over the last 12 months CORT made 145.05%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months CORT made 21.04%, while XLV made -6.89%.
Performance Comparison CORT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CORT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.3% | -5.6% | 27.4% | 135% |
| US NASDAQ 100 | QQQ | -0% | -6% | 28.2% | 136% |
| German DAX 40 | DAX | 1.9% | -3.8% | 11% | 116% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0% | -3.6% | 25.6% | 134% |
| Hongkong Hang Seng | HSI | -0.8% | -9.6% | 8.4% | 118% |
| India NIFTY 50 | INDA | 1.5% | -3.2% | 28.4% | 147% |
| Brasil Bovespa | EWZ | -2.6% | -5% | 7.2% | 136% |
CORT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.1% | -6% | 24.6% | 122% |
| Consumer Discretionary | XLY | 0.3% | -2.7% | 37.3% | 127% |
| Consumer Staples | XLP | 0% | -4.3% | 25.9% | 138% |
| Energy | XLE | -6.1% | -7.4% | 23.8% | 142% |
| Financial | XLF | 1.3% | -1.9% | 24.6% | 121% |
| Health Care | XLV | -2.2% | -8.9% | 27.9% | 150% |
| Industrial | XLI | 0.8% | -4.8% | 21.8% | 127% |
| Materials | XLB | 0.4% | -5.9% | 26.6% | 146% |
| Real Estate | XLRE | -0.8% | -5.5% | 26.4% | 132% |
| Technology | XLK | -0.6% | -6.5% | 27% | 141% |
| Utilities | XLU | -1.7% | -5% | 19% | 124% |
| Aerospace & Defense | XAR | 0.7% | -10.3% | 10.5% | 102% |
| Biotech | XBI | 0.1% | -12.3% | 38.2% | 153% |
| Homebuilder | XHB | 1.3% | 0.5% | 42.8% | 154% |
| Retail | XRT | 3.7% | -4.3% | 35.3% | 144% |
CORT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.1% | -23.2% | 17.5% | 142% |
| Natural Gas | UNG | 0.5% | -1.9% | 9.1% | 160% |
| Gold | GLD | -3.9% | -10.7% | -2.8% | 98% |
| Silver | SLV | 0.5% | -15.9% | 7.8% | 123% |
| Copper | CPER | 2.3% | -6.2% | 12.5% | 137% |
CORT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.8% | -5.2% | 28.8% | 149% |
| iShares High Yield Corp. Bond | HYG | -0.8% | -5% | 23.7% | 136% |